Raiffeisen Bank International AG Takes Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Raiffeisen Bank International AG bought a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 120,000 shares of the company's stock, valued at approximately $4,630,000. Raiffeisen Bank International AG owned 0.13% of Acadia Healthcare as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Treasurer of the State of North Carolina grew its holdings in Acadia Healthcare by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company's stock valued at $1,586,000 after purchasing an additional 250 shares during the period. Nisa Investment Advisors LLC lifted its holdings in Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after purchasing an additional 301 shares in the last quarter. Coldstream Capital Management Inc. boosted its holdings in Acadia Healthcare by 4.9% in the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company's stock worth $257,000 after buying an additional 303 shares during the last quarter. Covestor Ltd boosted its holdings in Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock worth $58,000 after buying an additional 310 shares during the last quarter. Finally, Pacer Advisors Inc. increased its stake in Acadia Healthcare by 2.4% during the 4th quarter. Pacer Advisors Inc. now owns 13,847 shares of the company's stock worth $549,000 after buying an additional 325 shares in the last quarter.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Guggenheim assumed coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They set a "buy" rating and a $36.00 price objective on the stock. KeyCorp reduced their price objective on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Bank of America dropped their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. Royal Bank of Canada dropped their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. Finally, Mizuho cut their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $47.94.

Acadia Healthcare Price Performance

Shares of ACHC stock traded up $0.12 during trading hours on Tuesday, hitting $25.20. The company's stock had a trading volume of 1,402,506 shares, compared to its average volume of 1,707,070. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The business has a fifty day moving average of $26.12 and a 200-day moving average of $35.37. Acadia Healthcare Company, Inc. has a twelve month low of $20.36 and a twelve month high of $82.41. The stock has a market cap of $2.32 billion, a price-to-earnings ratio of 8.26, a P/E/G ratio of 1.46 and a beta of 1.01.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $770.51 million for the quarter, compared to analysts' expectations of $769.90 million. During the same quarter in the prior year, the firm earned $0.84 EPS. Acadia Healthcare's quarterly revenue was up .3% on a year-over-year basis. As a group, equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.